Physician Leadership & Expertise

Marcel van den Brink is president of City of Hope Los Angeles and National Medical Center and serves as chief physician executive. A globally recognized leader in bone marrow transplantation and microbiome and cancer immunotherapy, he is widely respected for his collaborative leadership as well as

Michael Sullivan, M.D., is associate clinical professor and chair of the Department of Anesthesiology at City of Hope in Southern California.

Ping H. Wang, M.D., is chair of the Department of Diabetes, Endocrinology & Metabolism at City of Hope.

Chandana Lall, M.D., M.B.A., has had a distinguished career in radiology spanning more than 28 years, with a proven track record of excellence in advancing patient care, leading multidisciplinary teams and contributing to the advancement of the field of radiology. 

Eileen P. Smith, M.D., chair of the Department of Hematology & Hematopoietic Cell Transplantation, leads City of Hope with her expertise in hematology and oncology.

Ravi Salgia M.D., Ph.D., is the Arthur & Rosalie Kaplan Chair in Medical Oncology at City of Hope and an expert in the study and treatment of lung cancer, mesothelioma, thoracic and thymic malignancies and bronchial carcinoids.

Randy Taplitz, M.D., leads both investigator initiated and industry sponsored clinical trials, and has authored numerous high-impact publications within the field.

Dr. You is chair of the Department of Pathology, Hematologic Malignancies Translational Sciences, Beckman Research Institute of City of Hope.

Pediatric hematologist-oncologist Saro Armenian, D.O., M.P.H., is the Barron Hilton Chair in Pediatrics, with expertise in pediatric cancer, epidemiology and cancer survivorship.

Terence M. Williams, M.D., Ph.D., is professor and chair of the Department of Radiation Oncology, City of Hope in Duarte, Southern California.

Anesthesiologist Andrew T. Leitner, M.D., is chair of the Department of Supportive Care Medicine and the Arthur M. Coppola Family Chair in Supportive Care Medicine.

Yuman Fong, M.D., is an internationally recognized expert in cancer of the liver, gallbladder and bile ducts. He has led the research effort to employ genetically modified viruses to destroy cancer cells.